Friday, June 05, 2015 12:16:13 PM
However, I disagree with Czirr's assertion that one newsletter writer was the reason for the loss of 80% of our market cap last year. (Since it was brought up in the Q&A, I feel I need to respond to Czirr's comments.) I remember that morning very well and I did not learn anything that morning from a newsletter writer. But I do remember looking at that presentation and realizing how screwed I was.
Based on the high expectations we all had for Cohort 2 under the original protocol, many of us had overloaded on the stock and even purchased call options. Changing the protocol meant that we could no longer see any sort of positive "progression" from the Cohort 1 results and our share price tanked. (I for one would not have overloaded or bought call options had I known of the change in protocol.) Yes that newsletter writer undoubtedly helped things along, but he was not the only reason for the initial decline and is certainly not responsible for the continued depression of our share price a year after the fact.
For a long time I thought that they had not disclosed the change in protocol for Cohort 2. Recently, it was pointed out that the change in protocol could have been "deduced" from information in a slide in one of the presentations so I guess the change was technically disclosed. However, I will not be investing additional capital in GALT right now because I don't want to worry that I didn't dissect their slides well enough to insure that I am fully informed.
The science is still strong (actually it's even stronger) so why hasn't the share price recovered. I continue to believe that the fact that GALT's share price dropped so far and has not recovered is because the investing public has lost confidence in this management team. Everybody who was invested in GALT previously was negatively affected by the Cohort 2 fiasco and many (or most) feel that management was responsible. We need those investors to come back and they have not. Before you can fix a problem you have to first be willing to admit that there is a problem.
The fact that management wants to place all the blame for the Cohort 2 disaster on one newsletter writer instead of accepting at least some responsibility themselves tells me that apparently, there is still a problem. Management needs to get professional help to rebuild/regain the confidence of the investment community.
Perhaps management is not being allowed to do any kind of mea culpa due to the on-going lawsuit? Perhaps once the lawsuit is history we will see a real effort to rebuild investor confidence in our management team; an effort that would include a commitment to full and more transparent disclosure in the future.
Recent GALT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 05:50:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:55:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:53:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:51:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:50:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:48:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:47:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:44:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:43:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:40:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 04:23:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 01:07:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 01:41:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 04:42:44 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 09:50:50 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 01:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 10:19:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/13/2023 02:21:40 PM
- UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:45:52 PM
- Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:55:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM